Webcast Alert: Lippert/Heilshorn Life Sciences Conference Presentation (Aradigm)

* Reuters is not responsible for the content in this press release.

Tue Mar 24, 2009 5:34pm EDT 

NEW YORK--(Business Wire)--
Aradigm (ARDM) announces the following Webcast: 

What: Lippert/Heilshorn Life Sciences Conference Presentation 

When: March 26, 2009 @ 2:00 PM Eastern 

Where: http://www.investorcalendar.com/ClientPage.asp?ID=142720

How: Live over the Internet -- Simply log on to the web at the address above. 

Contact: Cheryl Palazzo, 212-838-3777, cpalazzo@lhai.com

If you are unable to participate during the live webcast, the call will be
available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=142720
or http://www.investorcalendar.com/

The Company is an emerging specialty pharmaceutical company focused on the
development and commercialization of a portfolio of drugs delivered by
inhalation for the treatment of severe respiratory diseases by pulmonologists.
Current activities include partnered activities on inhaled treprostinil for the
treatment of pulmonary arterial hypertension with Lung Rx, Inc (a wholly owned
subsidiary of United Therapeutics Corporation) and other self-initiated
development and partnered programs addressing the treatment of cystic fibrosis,
bronchiectasis, pulmonary hypertension, asthma and COPD, inhalation anthrax
infections and smoking cessation. 





For the Lippert/Heilshorn Life Sciences Conference Presentation
Cheryl Palazzo, 212-838-3777
cpalazzo@lhai.com



Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.